University of Massachusetts
Worcester, Massachusetts, 01655, United States
NCT Number: NCT01583166
The purpose of this study is to determine if there is a difference in post-operative voiding function between subjects receiving local anesthetic and those receiving placebo at the time of mid-urethral sling placement. The secondary objective is to evaluate pain after the procedure in the two groups.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Worcester, Massachusetts, 01655, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
10ml 0.5% bupivacaine
Other names: Marcaine
10ml 0.9% sodium chloride
Other names: Sodium Chloride
1:200,000 epinephrine
Time frame: 2 weeks
Study team assessment of whether the use of local anesthetic has any affect on the percentage of patients who pass their post-operative bladder challenge. This is determined by their voided volume and post-void residual.
Time frame: 2-3 hours
Visual analog score at 2 hours post op will be compared in the two groups. The scale ranges from 0 (no pain) to a maximum of 10 (unbearable pain)
Time frame: 6-7 hours
Visual analog score at 6 hours post op will be compared in the two groups. The scale ranges from 0 (no pain) to a maximum of 10 (unbearable pain)
Time frame: At enrollment
Participants asked to report on pre-operative level of pain using a Visual Analog Scale. The scale is participant reported and ranges from 0 representing no pain to 10 representing unbearable pain.
University of Massachusetts, Worcester
Other
Acronym: URINE&ME
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07668128
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Taipei City, Banqiao Dist, Taiwan
View Trial DetailsNCT03913845
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Bethel Park, Pennsylvania, United States
View Trial DetailsNCT02785016
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Frauenfeld, Thurgau, Switzerland
View Trial DetailsNCT07095283
Behavior, Female Urogenital Diseases
Elche, Alicante, Spain
View Trial Details